News
CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across ...
Chemotherapy-free approach shows promising tumour response ahead of surgery Immutep Limited (ASX:IMM; NASDAQ:IMMP) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback